Printer Friendly

Institut National de la Sante et de la Recherche Medicale obtains United States patent.

Institut National de la Sante et de la Recherche Medicale (Paris, France) has patented an isolated polypeptide constitutive of splice variants for human serotonin receptor whereof the amino acid sequence is selected among the sequence SEQ ID No. 2 of the 5-HT.sub.4(c) polypeptide variant or the sequence SEQ ID No. 4 of the 5-HT.sub.4(d) polypeptide variant, or any polypeptide fragment or biologically active derivative thereof. The invention also concerns the inverse agonist effect of ML 10375 on 5-HT4(c) and 5-HT4(d) receptors. (US 6,506,580)
COPYRIGHT 2003 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:for an isolated polypeptide
Comment:Institut National de la Sante et de la Recherche Medicale obtains United States patent.(for an isolated polypeptide)
Publication:BIOTECH Patent News
Article Type:Brief Article
Geographic Code:4EUFR
Date:Jan 1, 2003
Words:93
Previous Article:Pfizer obtains United States patent.
Next Article:Monsanto obtains United States patent.
Topics:


Related Articles
Pleins feux sur l'innovation. (Nouvelles de FedNor).
Un reseau en biotechnologie? Une realite dans le Nord: le monde entier a des raisons de se rejouir de ce qui s'accomplit dans le Nord de l'Ontario....
Environment and health: capacity building for the future/ Environnement et sante: augmenter le potentiel pour le futur.
Institut National de la Sante et de Recherche Medicale obtains United States patent.
Dr. Jacques Benveniste.
Global policy change and women's access to safe abortion: the impact of the World Health Organization's guidance in Africa/Changement de la politique...
Fluoroquinolone-resistant group B streptococci in acute exacerbation of chronic bronchitis.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters